Company / EPS (Basic)
Aspira Women's Health Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.93
FY2025
5-year range
-$3.85 / -$0.18
FY2021-FY2025
Trend
+48.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-3.85 to $-0.93 over the past 2 years.
Based on SEC 10-K filings.
-0.93 in FY2025.
Improved from $-3.85 to $-0.93 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 48.6% year-over-year.
- Peak eps (basic) was recorded in FY2019.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -89.08 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.93 | +48.6% |
| FY2024 | -$1.81 | +53.0% |
| FY2023 | -$3.85 | -1275.0% |
| FY2022 | -$0.28 | -55.6% |
| FY2021 | -$0.18 | +0.0% |
| FY2020 | -$0.18 | -12.5% |
| FY2019 | -$0.16 | +20.0% |
| FY2018 | -$0.20 | +31.0% |
| FY2017 | -$0.29 | +29.3% |
| FY2016 | -$0.41 | +22.6% |